SCHEMBL25142286

SCHEMBL25142286

Clc1cc(N2CCN(C3COC3)CC2)ncn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 2/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ OGA O60502 1/20 0.45
▸ HRH4 Q9H3N8 2/20 0.38
▸ CYP2C19 P33261 2/20 0.37
▸ HRH3 Q9Y5N1 3/20 0.37
▸ PIK3CD O00329 1/20 0.36
▸ KMO O15229 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36
▸ P4HTM Q9NXG6 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PRMT5 O14744 1/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL564552 0.83 HRH4 (0.50) OGAHRH4HRH3KCNH2LRRK2
SCHEMBL20241721 0.82 PIK3CA (0.42) JAK2TYK2HRH4CYP2C19PIK3CD
SCHEMBL12295191 0.82 PIM1 (0.41) JAK2TYK2HRH4CYP2C19PIK3CD
SCHEMBL12295201 0.78 JAK2 (0.39) JAK2TYK2OGAHRH4CYP2C19
SCHEMBL14868457 0.78 HRH4 (0.43) JAK2TYK2HRH4CYP2C19HRH3
SCHEMBL14872324 0.78 HRH4 (0.50) JAK2TYK2HRH4CYP2C19PIK3CD
SCHEMBL23571141 0.78 MAP4K4 (0.46) OGAHRH4CYP2C19KMOLRRK2
SCHEMBL23554662 0.78 LRRK2 (0.47) JAK2TYK2OGALRRK2
SCHEMBL23523535 0.78 LRRK2 (0.47) JAK2TYK2OGALRRK2
SCHEMBL2570384 0.77 CYP2C19 (0.58) OGACYP2C19KMOLRRK2P4HTM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3694330-B1 INDAZOLYL-SPIRO[2.2]PENTANE-CARBONITRILE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2023-04-19 — — EP disclosed
Send feedback